I can completely see your point of investing with high risk for future return. I just wanted to make sure that everyone was aware of the relatively high debt.I take it you are TFV?I probably should have been more clear in my post that "weak balance sheet" included the substantial debt burden KARE carries. I should also clarify that when I say KARE is "fairly valued" at 3.00, that is NOT my version of a "buy" recommendation. I try to buy companies at prices well below fair value. I don't think I would pay more than 1.50 for KARE based on what I know right now.I believe the current price of about 3.00 reflects the expectation that KARE will be able to get a new credit facility on fairly decent terms. Therefore, I'm not expecting any spike up if/when the terms of a new credit facility are announced and I think there's a good chance the price will go down if the market is not pleased with the terms. Do you have a view on this?Slee
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat